| Literature DB >> 12524421 |
Michael L Doyle1, Shin-Shay Tian, Stephen G Miller, Linda Kessler, Audrey E Baker, Michael R Brigham-Burke, Susan B Dillon, Kevin J Duffy, Richard M Keenan, Ruth Lehr, Jon Rosen, Lumelle A Schneeweis, John Trill, Peter R Young, Juan I Luengo, Peter Lamb.
Abstract
Granulocyte colony-stimulating factor regulates neutrophil production by binding to a specific receptor, the granulocyte colony-stimulating factor receptor, expressed on cells of the granulocytic lineage. Recombinant forms of granulocyte colony-stimulating factor are used clinically to treat neutropenias. As part of an effort to develop granulocyte colony-stimulating factor mimics with the potential for oral bioavailability, we previously identified a nonpeptidyl small molecule (SB-247464) that selectively activates murine granulocyte colony-stimulating factor signal transduction pathways and promotes neutrophil formation in vivo. To elucidate the mechanism of action of SB-247464, a series of cell-based and biochemical assays were performed. The activity of SB-247464 is strictly dependent on the presence of zinc ions. Titration microcalorimetry experiments using a soluble murine granulocyte colony-stimulating factor receptor construct show that SB-247464 binds to the extracellular domain of the receptor in a zinc ion-dependent manner. Analytical ultracentrifugation studies demonstrate that SB-247464 induces self-association of the N-terminal three-domain fragment in a manner that is consistent with dimerization. SB-247464 induces internalization of granulocyte colony-stimulating factor receptor on intact cells, consistent with a mechanism involving receptor oligomerization. These data show that small nonpeptidyl compounds are capable of selectively binding and inducing productive oligomerization of cytokine receptors.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12524421 DOI: 10.1074/jbc.M209220200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157